Trials / Completed
CompletedNCT05191498
Intratumoral Holmium Microspheres Brachytherapy for Patients With Pancreatic Cancer
Intratumoral Holmium Microspheres Brachytherapy for Patients With Pancreatic Cancer; a Single Center, Non-randomized, Feasibility Study in an Open Surgical Setting - the SLOTH1 Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 3 (actual)
- Sponsor
- Radboud University Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a feasibility study in which patients with pancreatic cancer are treated with intratumoral holmium microsphere injections.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | QuiremSpheres® | Intratumoral injection of QuiremSpheres® up to a dose of 150 Gy. |
Timeline
- Start date
- 2021-12-13
- Primary completion
- 2024-02-18
- Completion
- 2024-02-18
- First posted
- 2022-01-13
- Last updated
- 2024-04-11
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT05191498. Inclusion in this directory is not an endorsement.